Harriett recounts the experiences of a constituent who was first infected with contaminated blood products in 1976 and as a result has been unable to work since 1997. She calls for the review to ensure that compensation levels will reflect the length of time individuals have been unable to work and to ensure that patients in this position never again experience financial disadvantage from this terrible situation. Harriett Baldwin (West Worcestershire) (Con): Thank you for allowing me to speak in this historic debate, Mr Deputy Speaker. Like so many of my colleagues, this issue has been brought to my attention by the impact it has had on the life of a constituent-in my case, the constituent is Colette Wintle. Colette was born in 1959 and was diagnosed with haemophilia in 1962. When she went to have her tonsils out in 1976, she was given American blood products which first caused her infection with hepatitis. In 1982, at a hospital in Kent, she was given factor VIII concentrate, which infected her with hepatitis C. In 1985, at a hospital in London, she was once again given treatment with blood products, which made her very ill with hepatitis C, although mercifully she did not contract HIV. Subsequently, she has been so weak with illness that she had to stop work at the age of 38. She has contracted cirrhosis of the liver and lives in fear of developing liver cancer in her damaged liver. As we all know, it is not possible for doctors to undo the damage to Colette's health and it is not possible for her ever to be adequately compensated for the harm that was done to her by the infected blood products. The question is what we should do now, as a society, to compensate people such as Colette and her family. We have heard about the Skipton Fund, and I think that everyone in this debate acknowledges that the payments of a maximum of £45,000 are not adequate to compensate someone for that treatment. We have also talked a lot about different numbers, and I wish to help the House. As 4,672 people have been infected over the years, a payment of £1 million to each of them would involve £4.672 billion. A payment of £100,000 to every sufferer would involve £467.2 million-I believe I have those figures right. That puts the £3 billion cost into context; it would work out to be £642,000 per individual. But Colette has not been able to work since she was 38 and has had to pay for her NHS prescriptions. She looks ahead to the future, but her general practitioner is unable to assure her that she will have access to specialist nursing at home if her condition worsens. I welcome what the Minister said in her statement and the fact that she will look urgently at a number of issues. However, will she clarify whether the compensation that will be recommended by the review will reflect the length of time that individuals have had to suffer and been unable to work because of the illness? Will the review also examine something that is being debated a lot with the Department for Work and Pensions: what happens when an individual is being assessed for their ability to work? Can we agree in this House today that it would be good if we exempted all these individuals-the 2,700 surviving patients-from any further assessment of their capacity to work? No money could ever compensate these victims for what has happened. Their health can never be repaired, but let us ensure that as a result of this debate and of this inquiry we ensure, once and for all, that the patients do not experience further financial disadvantage from this terrible situation. 3.34 pm | Hansard